✦ LIBER ✦

Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas

✍ Scribed by Kelaidi, C; Rollot, F; Park, S; Tulliez, M; Christoforov, B; Calmus, Y; Podevin, P; Bouscary, D; Sogni, P; Blanche, P

Book ID: 110055966
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 107 KB
Volume: 18
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403443

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to peginterferon treatment in h

Response to peginterferon treatment in hepatitis C virus-associated splenic lymphoma with villous lymphocytes

✍ Mehmet Kanbay; Haldun Selcuk; Gurden Gur; Neslihan Dagli; Sema Karakus; Ugur Yil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Genetic variability in hepatitis C virus

Genetic variability in hepatitis C virus and its role in antiviral treatment response

✍ M. Torres-Puente; J. M. Cuevas; N. Jiménez-Hernández; M. A. Bracho; I. García-Ro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

330 MOLECULAR SIGNATURES OF HEPATITIS C

330 MOLECULAR SIGNATURES OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEINS AND RESPONSE TO ANTIVIRAL TREATMENT

✍ R. Moenne-Loccoz; C. Rajafinjatovo; S. Fafi-Kremer; F. Habersetzer; A. Ananna; M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Impact of liver steatosis on the antivir

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis

✍ M. Soresi; S. Tripi; V. Franco; L. Giannitrapani; A. Alessandri; F. Rappa; O. Vu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Mechanisms of non-response to antiviral

Mechanisms of non-response to antiviral treatment in chronic hepatitis C

✍ Stephane Chevaliez; Tarik Asselah 📂 Article 📅 2011 🏛 Elsevier 🌐 French ⚖ 264 KB

Caspase activation is required for antiv

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

✍ Xandra Volkmann; Markus Cornberg; Heiner Wedemeyer; Frank Lehner; Michael P. Man 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 1 views

Only half of patients with chronic hepatitis C virus (HCV) infection and genotype-1 show a sustained antiviral response to the current antiviral therapy. The reason this treatment fails is unclear, and no reliable marker exists that predicts the treatment outcome. In the present study, we investigat